Sensile Medical formed a strategic alliance with Sanofi and Verily to develop and commercialize a connected insulin patch pump

OLTEN, Switzerland with its long-standing commitment to addressing the needs of people living with diabetes, Sanofi announced a new development and commercialization alliance at the American Diabetes Association (ADA) 78th Scientific Sessions in Orlando, Florida, U.S. “Our goal is to develop a new type of pump technology that is simple to use and appropriate for people with Type 2 diabetes, as well as by those with Type 1 diabetes who are the primary users of insulin pumps”

Sensile Medical, Sanofi and Verily (formerly Google Life Sciences) are collaborating on development and commercialization of a connected insulin patch pump.
The 3 parties develop and commercialize a new generation of “all-in-one” pre-filled insulin patch pump, primarily to serve people living with type 2 diabetes.
The alliance will leverage Sanofi’s expertise in patient-centered diabetes solutions and insulins, Sensile Medical’s leadership in developing micro-pump technologies for medical use, and Verily’s experience in micro-electronic integration and digital healthcare technology.

“Our goal is to develop a new type of pump technology that is simple to use and appropriate for people with Type 2 diabetes, as well as by those with Type 1 diabetes who are the primary users of insulin pumps” said Derek Brandt, CEO of Sensile Medical.

Source: https://www.businesswire.com/